Research & Academia

UCSF Dermatology Grand Rounds 14 October 2026

Wednesday, October 14 at 8:00 am - 10:00 am Add to Calendar 2026-10-14 08:00:00 2026-10-14 10:00:00 UCSF Dermatology Grand Rounds 14 October 2026 Grand Rounds and Patient Cases Tim Berger, MD Lectureship In-person Herbst Hall, 1600 Divisadero Street, 2nd Floor  From Scratch to Science: The Remarkable Journey of Itch   Honoring Tim Berger, a Pioneer in the  Care of Itch Gil Yosipovitch, MD, Professor and Stiefel Endowed Chair of Medical Dermatology,Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine Learning objectives : 1. Describe the evolution of chronic itch from a poorly understood symptom to a distinct neuroimmune disorder, highlighting key advances in itch biology and sensory neuroscience. 2. Apply current understanding of itch mechanisms to the diagnosis and treatment of patients with chronic pruritus, including emerging targeted therapies. Gil Yosipovitch, MD has the following financial relationships with industry:Consulting Fee-Sanofi S.A.|Grant or research support-Sanofi S.A.|Grant or research support-Regeneron Pharmaceuticals, Inc.|Consulting Fee-Regeneron Pharmaceuticals, Inc.|Grant or researchsupport-Galderma (Any division)|Consulting Fee-Galderma (Any division)|Consulting Fee-Novartis Corporation Pharmaceuticals|Grant or research support-Novartis Corporation Pharmaceuticals|Honoraria-LEO|Consulting Fee-Lilly (Any division)|Consulting Fee-ZEN ZEMA|Consulting Fee-AbbVie (Any division)|Grant or research support-AbbVie (Any division) (Relationship has ended)  Department Of Dermatology Laura Harrison [email protected] America/Los_Angeles public

Grand Rounds and Patient Cases

Tim Berger, MD Lectureship

In-person

Herbst Hall, 1600 Divisadero Street, 2nd Floor 

From Scratch to Science: The Remarkable Journey of Itch 

 Honoring Tim Berger, a Pioneer in the  Care of Itch

Gil Yosipovitch, MD, Professor and Stiefel Endowed Chair of Medical Dermatology,Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine

Learning objectives :

1. Describe the evolution of chronic itch from a poorly understood symptom to a distinct neuroimmune disorder, highlighting key advances in itch biology and sensory neuroscience.

2. Apply current understanding of itch mechanisms to the diagnosis and treatment of patients with chronic pruritus, including emerging targeted therapies.

Gil Yosipovitch, MD has the following financial relationships with industry:Consulting Fee-Sanofi S.A.|Grant or research support-Sanofi S.A.|Grant or research support-Regeneron Pharmaceuticals, Inc.|Consulting Fee-Regeneron Pharmaceuticals, Inc.|Grant or researchsupport-Galderma (Any division)|Consulting Fee-Galderma (Any division)|Consulting Fee-Novartis Corporation Pharmaceuticals|Grant or research support-Novartis Corporation Pharmaceuticals|Honoraria-LEO|Consulting Fee-Lilly (Any division)|Consulting Fee-ZEN ZEMA|Consulting Fee-AbbVie (Any division)|Grant or research support-AbbVie (Any division) (Relationship has ended)